Insider Transactions in Q4 2021 at Inmune Bio, Inc. (INMB)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 17
2021
|
Scott Juda Director |
BUY
Open market or private purchase
|
Indirect |
2,500
+7.69%
|
$32,500
$13.55 P/Share
|
|
Nov 03
2021
|
Raymond Joseph Tesi President and CEO |
SELL
Open market or private sale
|
Direct |
3,626
-0.24%
|
$72,520
$20.0 P/Share
|
|
Nov 03
2021
|
David J Moss Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,025
-0.08%
|
$20,500
$20.0 P/Share
|
|
Nov 03
2021
|
Mark William Lowdell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
701
-0.05%
|
$14,020
$20.0 P/Share
|
|
Oct 27
2021
|
David J Moss Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,079
-0.17%
|
$41,580
$20.0 P/Share
|
|
Oct 27
2021
|
Mark William Lowdell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,357
-0.16%
|
$47,140
$20.0 P/Share
|
|
Oct 27
2021
|
Raymond Joseph Tesi President and CEO |
SELL
Open market or private sale
|
Direct |
6,517
-0.43%
|
$130,340
$20.0 P/Share
|
|
Oct 25
2021
|
David J Moss Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13
-0.0%
|
$260
$20.0 P/Share
|
|
Oct 22
2021
|
Mark William Lowdell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
400
-0.03%
|
$8,000
$20.0 P/Share
|
|
Oct 22
2021
|
David J Moss Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,142
-0.09%
|
$22,840
$20.0 P/Share
|
|
Oct 22
2021
|
Raymond Joseph Tesi President and CEO |
SELL
Open market or private sale
|
Direct |
23,616
-1.55%
|
$472,320
$20.0 P/Share
|